You have 9 free searches left this month | for more free features.

exosomes;lncRNA; lung cancer;

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-small Cell Lung Cancer With Central Nervous System

Recruiting
  • Lung Cancer With Central Nervous System Metastasis
  • lung cancer with brain /leptomeningeal metastasis
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 4, 2023

Urinary Exosome lncRNAs for Preoperative Diagnosis of Lymphatic

Not yet recruiting
  • Explore Whether lncRNA-ElNAT1 in Urine Exosomes Can be Used as a New Target for Preoperative Diagnosis of Lymph Node Metastasis
  • no intervention
  • Guangzhou, China
    Sun Yat-sen Memorial Hosptial
Mar 6, 2022

Peripheral and Pulmonary Blood

Recruiting
  • Lung Cancer
  • Diagnosis
  • frozen blood plasma samples
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Oct 16, 2022

Lung Cancer, Exosomes, Non Small Cell Lung Cancer Trial in Limoges (Blood samples at 2 sites: peripheral vein and tumor-draining

Recruiting
  • Lung Cancer
  • +2 more
  • Blood samples at 2 sites: peripheral vein and tumor-draining vein
  • Limoges, France
    CHU de Limoges
Nov 3, 2021

NSCLC Trial (Anlotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jan 19, 2022

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for

Completed
  • Lung Cancer (Diagnosis)
  • collect samples
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Nov 15, 2021

Advanced Gastric Carcinoma, Immunotherapy Trial in Beijing (Circulating exosomal lncRNA-GC1 detection)

Completed
  • Advanced Gastric Carcinoma
  • Immunotherapy
  • Circulating exosomal lncRNA-GC1 detection
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 7, 2022

Lung Cancer by Combining Exosomal Analysis of Hypoxia With

Recruiting
  • Lung Cancer
    • Stevenage, United Kingdom
      Borthwick Research Unit, Lister Hospital
    Nov 13, 2020

    NSCLC Patients Trial in Shanghai (pabolizumab, nafulizumab)

    Recruiting
    • NSCLC Patients
    • Shanghai, Shanghai, China
      Cancer hospital Fudan University
    Jun 9, 2020

    Sepsis Complicated With ARDS Trial in Tianjin (Blood samples and alveolar lavage fluid were collected)

    Recruiting
    • Sepsis Complicated With ARDS
    • Blood samples and alveolar lavage fluid were collected
    • Tianjin, Tianjin, China
      Plasma and alveolar lavage fluid
    Jul 24, 2022

    Multicenter Clinical Research for Early Diagnosis of Lung Cancer

    Active, not recruiting
    • Lung Cancer
    • Exosome sampling
    • Seoul, Guro-gu, Korea, Republic of
      Korea University Guro Hospital
    Dec 10, 2021

    Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic

    Enrolling by invitation
    • Pancreatic
      • Shanghai, Shanghai, China
        Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, Sc
      Oct 25, 2023

      Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer

      Recruiting
      • Gastric Cancer
      • Measurement of levels of circulating exosomal lncRNA-GC1
      • Beijing, Beijing, China
        Xinxin Wang
      Jun 24, 2022

      Chronicization of Radiation-induced Acute Intestinal Injury

      Not yet recruiting
      • Radiation-induced Intestinal Injury
      • NCRT+TME
      • (no location specified)
      Feb 19, 2023

      Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients

      Recruiting
      • Gastric Cancer
      • Chemotherapy Effect
      • Detection of levels of circulating EV-derived lncRNA-GC1
      • Beijing, Beijing, China
        Chinese PLA General Hospital Ethics Committee
      Dec 12, 2022

      Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

      Recruiting
      • Advanced Lung Non-Small Cell Carcinoma
      • +9 more
      • Biopsy
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Aug 2, 2022

      Anti Aging Trial in Isfahan (exosime injection)

      Recruiting
      • Anti Aging
      • exosime injection
      • Isfahan, Iran, Islamic Republic of
        Isfahan University of Medical Sciences
      Apr 1, 2023

      Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

      Active, not recruiting
      • Non-Squamous Non-Small Cell Lung Carcinoma
      • +7 more
      • Nivolumab
      • +3 more
      • Abington, Pennsylvania
      • +1 more
      Sep 14, 2022

      Lung Diseases Trial (exosomes)

      Not yet recruiting
      • Lung Diseases
      • exosomes
      • (no location specified)
      May 8, 2023

      Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

      Recruiting
      • Lung Cancer
      • Yiwu, Zhejiang, China
        The Fourth Affiliated Hospital of Zhejiang University
      Dec 16, 2022

      Extracellular Vesicles and Particles as Biomarkers of Recurrence

      Recruiting
      • Non-Small Cell Lung Cancer
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Jun 16, 2022

        Therapeutic Efficiency in Lung Squamous Carcinoma

        Recruiting
        • Lung Neoplasm
        • +2 more
        • collect plasma samples and clinical features
        • Tianjin, Tianjin, China
          TianjinCIH
        May 10, 2023

        Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

        Not yet recruiting
        • HCC
        • No intervention was required for patients or control group in this study
        • (no location specified)
        Apr 21, 2023

        Irritable Bowel Disease Trial in Louisville (Sigmoidoscopy and biopsy, blood work)

        Completed
        • Irritable Bowel Disease
        • Sigmoidoscopy and biopsy, blood work
        • Louisville, Kentucky
          University of Louisville
        Nov 2, 2022

        Hair Loss, Alopecia Trial in Isfahan (Exosome)

        Recruiting
        • Hair Loss
        • Alopecia
        • Exosome
        • Isfahan, Iran, Islamic Republic of
          Leila Dehghani
        Dec 17, 2022